This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Helmholtz Zentrum Munchen Deutsches Forschungszentrum Fur Gesundheit Und Umwelt. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Anna Kosinska: Innovator in Hepatitis B Virus Treatment
Introduction
Anna Kosinska is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of medical research, particularly in the development of innovative treatments for viral infections.
Latest Patents
Anna Kosinska holds a patent for "Means and methods for treating HBV." This invention relates to an improved recombinant vaccination vector designed for the treatment or vaccination against the hepatitis B virus (HBV). The patent also encompasses pharmaceutical compositions or vaccines that include this recombinant vaccination vector. Furthermore, it details a method of vaccination against HBV, along with kits that comprise a vaccine featuring the recombinant vaccination vector.
Career Highlights
Anna is affiliated with Helmholtz Zentrum München—Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH). Her work at this esteemed research institution has positioned her as a key player in the fight against hepatitis B.
Collaborations
Some of her notable coworkers include Ulrike Protzer and Tanja Bauer, who collaborate with her on various research initiatives.
Conclusion
Anna Kosinska's innovative work in developing treatments for hepatitis B virus showcases her dedication to advancing medical science. Her contributions are vital in the ongoing battle against viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile